About this trial
The registry population consists of patients presenting with complex aortic pathologies amenable to endovascular aortic repair that requires the incorporation of bridging stents to maintain visceral artery perfusion
Eligibility criteria
Qualifiers
Informed Consent Form (ICF) is signed by Subject.
Age ≥ 18 years at time of informed consent signature.
Patient presents with thoracoabdominal, pararenal, juxtarenal, or short-neck infrarenal aortic pathology suitable for endovascular repair.
Patient requires the incorporation of ≥ 1 visceral artery and is suitable for use of at least 1 GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (BXB) as a bridging stent (Note: Up to six (6) visceral arteries may be incorporated).
Disqualifiers
Patient has a prior visceral artery stenting not associated with registry procedure.
Patient treated for acute or sub-acute dissection, <90 days from onset of symptoms
Patient is intended to be treated with a parallel grafting (e.g., chimney, periscope, sandwich) or octopus technique.
Known hypersensitivity to heparin or a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II.
Trial design
Treatments tested in this trial
- Not listed